A Find-and-Replace Approach to Fixing the Mutation Underlying Sickle Cell Disease

Josh Lehrer, CEO of Graphite Bio, discusses his company’s experimental sickle cell gene editing therapy, how it works, and what makes it a next-generation gene editor. @globalgenes #RARECast